<?xml version='1.0' encoding='utf-8'?>
<document id="26855561"><sentence text="Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers."><entity charOffset="11-21" id="DDI-PubMed.26855561.s1.e0" text="probenecid" /><entity charOffset="26-36" id="DDI-PubMed.26855561.s1.e1" text="cimetidine" /><entity charOffset="64-75" id="DDI-PubMed.26855561.s1.e2" text="nemonoxacin" /><pair ddi="false" e1="DDI-PubMed.26855561.s1.e0" e2="DDI-PubMed.26855561.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26855561.s1.e0" e2="DDI-PubMed.26855561.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s1.e0" e2="DDI-PubMed.26855561.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26855561.s1.e1" e2="DDI-PubMed.26855561.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s1.e1" e2="DDI-PubMed.26855561.s1.e2" /></sentence><sentence text="To investigate the effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in humans"><entity charOffset="30-40" id="DDI-PubMed.26855561.s2.e0" text="probenecid" /><entity charOffset="45-55" id="DDI-PubMed.26855561.s2.e1" text="cimetidine" /><entity charOffset="83-94" id="DDI-PubMed.26855561.s2.e2" text="nemonoxacin" /><pair ddi="false" e1="DDI-PubMed.26855561.s2.e0" e2="DDI-PubMed.26855561.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26855561.s2.e0" e2="DDI-PubMed.26855561.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s2.e0" e2="DDI-PubMed.26855561.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26855561.s2.e1" e2="DDI-PubMed.26855561.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s2.e1" e2="DDI-PubMed.26855561.s2.e2" /></sentence><sentence text="" /><sentence text="Two independent, open-label, randomized, crossover studies were conducted in 24 (12 per study) healthy Chinese volunteers" /><sentence text=" In Study 1, each volunteer received a single oral dose of 500 mg of nemonoxacin alone or with 1"><entity charOffset="69-80" id="DDI-PubMed.26855561.s5.e0" text="nemonoxacin" /></sentence><sentence text="5 g of probenecid divided into three doses within 25 hours" /><sentence text=" In Study 2, each volunteer received a single oral dose of 500 mg of nemonoxacin alone or with multiple doses of cimetidine (400 mg thrice daily for 7 days)"><entity charOffset="69-80" id="DDI-PubMed.26855561.s7.e0" text="nemonoxacin" /><entity charOffset="113-123" id="DDI-PubMed.26855561.s7.e1" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.26855561.s7.e0" e2="DDI-PubMed.26855561.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26855561.s7.e0" e2="DDI-PubMed.26855561.s7.e1" /></sentence><sentence text=" The plasma and urine nemonoxacin concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods"><entity charOffset="22-33" id="DDI-PubMed.26855561.s8.e0" text="nemonoxacin" /></sentence><sentence text="" /><sentence text="Coadministration of nemonoxacin with probenecid reduced the renal clearance (CLr) of nemonoxacin by 22"><entity charOffset="20-31" id="DDI-PubMed.26855561.s10.e0" text="nemonoxacin" /><entity charOffset="37-47" id="DDI-PubMed.26855561.s10.e1" text="probenecid" /><entity charOffset="85-96" id="DDI-PubMed.26855561.s10.e2" text="nemonoxacin" /><pair ddi="false" e1="DDI-PubMed.26855561.s10.e0" e2="DDI-PubMed.26855561.s10.e0" /><pair ddi="false" e1="DDI-PubMed.26855561.s10.e0" e2="DDI-PubMed.26855561.s10.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s10.e0" e2="DDI-PubMed.26855561.s10.e2" /><pair ddi="false" e1="DDI-PubMed.26855561.s10.e1" e2="DDI-PubMed.26855561.s10.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s10.e1" e2="DDI-PubMed.26855561.s10.e2" /></sentence><sentence text="6%, and increased the area under the plasma concentration-time curve from time 0 to infinity (AUC0-∞) by 26" /><sentence text="2%" /><sentence text=" Coadministration of nemonoxacin with cimetidine reduced the CLr of nemonoxacin by 13"><entity charOffset="21-32" id="DDI-PubMed.26855561.s13.e0" text="nemonoxacin" /><entity charOffset="38-48" id="DDI-PubMed.26855561.s13.e1" text="cimetidine" /><entity charOffset="68-79" id="DDI-PubMed.26855561.s13.e2" text="nemonoxacin" /><pair ddi="false" e1="DDI-PubMed.26855561.s13.e0" e2="DDI-PubMed.26855561.s13.e0" /><pair ddi="false" e1="DDI-PubMed.26855561.s13.e0" e2="DDI-PubMed.26855561.s13.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s13.e0" e2="DDI-PubMed.26855561.s13.e2" /><pair ddi="false" e1="DDI-PubMed.26855561.s13.e1" e2="DDI-PubMed.26855561.s13.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s13.e1" e2="DDI-PubMed.26855561.s13.e2" /></sentence><sentence text="3% and increased AUC0-∞ by 9" /><sentence text="4%" /><sentence text=" Coadministration of nemonoxacin with probenecid or cimetidine did not significantly affect the maximum concentration of nemonoxacin or the percentage of the administered dose recovered in the urine"><entity charOffset="21-32" id="DDI-PubMed.26855561.s16.e0" text="nemonoxacin" /><entity charOffset="38-48" id="DDI-PubMed.26855561.s16.e1" text="probenecid" /><entity charOffset="52-62" id="DDI-PubMed.26855561.s16.e2" text="cimetidine" /><entity charOffset="121-132" id="DDI-PubMed.26855561.s16.e3" text="nemonoxacin" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e0" e2="DDI-PubMed.26855561.s16.e0" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e0" e2="DDI-PubMed.26855561.s16.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e0" e2="DDI-PubMed.26855561.s16.e2" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e0" e2="DDI-PubMed.26855561.s16.e3" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e1" e2="DDI-PubMed.26855561.s16.e1" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e1" e2="DDI-PubMed.26855561.s16.e2" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e1" e2="DDI-PubMed.26855561.s16.e3" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e2" e2="DDI-PubMed.26855561.s16.e2" /><pair ddi="false" e1="DDI-PubMed.26855561.s16.e2" e2="DDI-PubMed.26855561.s16.e3" /></sentence><sentence text="" /><sentence text="Although probenecid reduced the CLr and increased the plasma exposure of nemonoxacin, these effects are unlikely to be clinically meaningful at therapeutic doses"><entity charOffset="9-19" id="DDI-PubMed.26855561.s18.e0" text="probenecid" /><entity charOffset="73-84" id="DDI-PubMed.26855561.s18.e1" text="nemonoxacin" /><pair ddi="false" e1="DDI-PubMed.26855561.s18.e0" e2="DDI-PubMed.26855561.s18.e0" /><pair ddi="false" e1="DDI-PubMed.26855561.s18.e0" e2="DDI-PubMed.26855561.s18.e1" /></sentence><sentence text=" Cimetidine had weaker, clinically meaningless effects on the pharmacokinetics of nemonoxacin"><entity charOffset="1-11" id="DDI-PubMed.26855561.s19.e0" text="Cimetidine" /><entity charOffset="82-93" id="DDI-PubMed.26855561.s19.e1" text="nemonoxacin" /><pair ddi="false" e1="DDI-PubMed.26855561.s19.e0" e2="DDI-PubMed.26855561.s19.e0" /><pair ddi="false" e1="DDI-PubMed.26855561.s19.e0" e2="DDI-PubMed.26855561.s19.e1" /></sentence><sentence text="" /></document>